Susanna Longo, MD, PhD, M.Sc., is a clinician–scientist specializing in Internal Medicine, with expertise in cardiometabolic diseases and gut microbiota–host interactions. She is a researcher at the University of Rome Tor Vergata and collaborates with international research institutions, including the Institut d’Investigació Biomèdica de Girona. Her translational research combines clinical phenotyping with multi-omics approaches, including metagenomics, metabolomics, and transcriptomics, to investigate the role of microbial metabolites in type 2 diabetes, MASLD, cardiovascular disease, and the gut–brain axis. Dr. Longo has authored numerous peer-reviewed publications and book chapters on gut microbiota and cardiometabolic risk. She serves as a reviewer and a member of the Topical Advisory Panel for international journals and is actively involved in national and international competitive research projects.
Susanna Longo, MD, PhD, M.Sc., is a clinician–scientist specializing in Internal Medicine, with expertise in cardiometabolic diseases and gut microbiota–host interactions. She is a researcher at the University of Rome Tor Vergata and collaborates with international research institutions, including the Institut d’Investigació Biomèdica de Girona. Her translational research combines clinical phenotyping with multi-omics approaches, including metagenomics, metabolomics, and transcriptomics, to investigate the role of microbial metabolites in type 2 diabetes, MASLD, cardiovascular disease, and the gut–brain axis. Dr. Longo has authored numerous peer-reviewed publications and book chapters on gut microbiota and cardiometabolic risk. She serves as a reviewer and a member of the Topical Advisory Panel for international journals and is actively involved in national and international competitive research projects.